Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer

Ruizan Shi(Shanxi Medical University), Yan Wang(Shanxi Medical University)
Oncology Reports
March 15, 2019
Cited by 27


Related Papers